{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"GoodRx Reports First Quarter 2023 Results - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"MUGnYXXpVW\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-reports-first-quarter-2023-results\/\">GoodRx Reports First Quarter 2023 Results<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-reports-first-quarter-2023-results\/embed\/#?secret=MUGnYXXpVW\" width=\"600\" height=\"338\" title=\"&#8220;GoodRx Reports First Quarter 2023 Results&#8221; &#8212; Market Newsdesk\" data-secret=\"MUGnYXXpVW\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"GoodRx Reports First Quarter 2023 Results First quarter financial results exceed previously announced guidance SANTA MONICA, Calif.&#8211;(BUSINESS WIRE)&#8211; GoodRx Holdings, Inc. (Nasdaq: GDRX) (\u201cGoodRx\u201d or the \u201cCompany\u201d), a leading digital healthcare platform, has released its financial results for the first quarter 2023. First Quarter 2023 Highlights Total revenue of $184.0 million, exceeding previously announced guidance Net loss of $3.3 million1; Net loss margin of 1.8% Adjusted Net Income2 of $29.5 million; Adjusted Net Income Margin2 of 16.0% Adjusted EBITDA2 of $53.2 million; Adjusted EBITDA Margin2 of 28.9%, exceeding previously announced guidance Net cash provided by operating activities of $32.3 million Over 450,000 prescribers3 engaged with us through Provider Mode since its launch Exited the quarter with over 7 million consumers &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230510005381r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"}